Bio Key International Stock Performance

BKYI Stock  USD 0.82  0.01  1.20%   
On a scale of 0 to 100, BIO Key holds a performance score of 5. The firm shows a Beta (market volatility) of -0.7, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning BIO Key are expected to decrease at a much lower rate. During the bear market, BIO Key is likely to outperform the market. Please check BIO Key's treynor ratio and the relationship between the semi variance and period momentum indicator , to make a quick decision on whether BIO Key's price patterns will revert.

Risk-Adjusted Performance

Modest

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in BIO Key International are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. Despite fairly weak basic indicators, BIO Key demonstrated solid returns over the last few months and may actually be approaching a breakup point. ...more
Last Split Factor
1:18
Dividend Date
2020-11-20
Last Split Date
2023-12-21
1
Acquisition by Michael DePasquale of 24000 shares of BIO Key subject to Rule 16b-3
05/01/2025
2
Acquisition by Michel Robert J of 3897 shares of BIO Key subject to Rule 16b-3
05/08/2025
3
Bio-key International Sees Revenue Growth and Expands Strategic Partnerships
05/16/2025
4
BIO-key and Runlevel Secure First Major IAM Deployment with a National Bank in Mozambique Extends Growing List of Banking Customers
05/27/2025
5
Acquisition by Michael DePasquale of 5000 shares of BIO Key at 0.81 subject to Rule 16b-3
06/03/2025
6
Acquisition by Michael DePasquale of 5000 shares of BIO Key at 0.78 subject to Rule 16b-3
06/13/2025
7
Bio-key CEO Michael DePasquale acquires 3,900 in shares - Investing.com
06/16/2025
8
International Defense Ministry Awards BIO-key over 600K in Follow-On Orders for Secure Biometric Access to Critical Information
06/17/2025
9
Acquisition by Knook Pieter Cornelis of 2098 shares of BIO Key subject to Rule 16b-3
06/18/2025
10
BIO-key Joins ISMS Forum to Advance Cybersecurityand Identity M
06/25/2025
11
BKYI SEC Filings - Bio-Key Intl Inc 10-K, 10-Q, 8-K Forms - Stock Titan
06/27/2025
12
Bio key international - AInvest
07/01/2025
Begin Period Cash Flow511.4 K
Total Cashflows From Investing Activities-13 K

BIO Key Relative Risk vs. Return Landscape

If you would invest  74.00  in BIO Key International on April 26, 2025 and sell it today you would earn a total of  8.00  from holding BIO Key International or generate 10.81% return on investment over 90 days. BIO Key International is currently generating 0.2064% in daily expected returns and assumes 2.8683% risk (volatility on return distribution) over the 90 days horizon. In different words, 25% of stocks are less volatile than BIO, and 96% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon.
  Expected Return   
       Risk  
Given the investment horizon of 90 days BIO Key is expected to generate 3.67 times more return on investment than the market. However, the company is 3.67 times more volatile than its market benchmark. It trades about 0.07 of its potential returns per unit of risk. The Dow Jones Industrial is currently generating roughly 0.23 per unit of risk.

BIO Key Market Risk Analysis

Today, many novice investors tend to focus exclusively on investment returns with little concern for BIO Key's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as BIO Key International, and traders can use it to determine the average amount a BIO Key's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.

Sharpe Ratio = 0.072

Best PortfolioBest Equity
Good Returns
Average Returns
Small ReturnsBKYI
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative Returns

Estimated Market Risk

 2.87
  actual daily
25
75% of assets are more volatile

Expected Return

 0.21
  actual daily
4
96% of assets have higher returns

Risk-Adjusted Return

 0.07
  actual daily
5
95% of assets perform better
Based on monthly moving average BIO Key is performing at about 5% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of BIO Key by adding it to a well-diversified portfolio.

BIO Key Fundamentals Growth

BIO Stock prices reflect investors' perceptions of the future prospects and financial health of BIO Key, and BIO Key fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on BIO Stock performance.

About BIO Key Performance

By evaluating BIO Key's fundamental ratios, stakeholders can gain valuable insights into BIO Key's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if BIO Key has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if BIO Key has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Days Of Inventory On Hand 107.09  101.74 
Return On Tangible Assets(0.57)(0.60)
Return On Capital Employed(0.99)(0.94)
Return On Assets(0.50)(0.52)
Return On Equity(1.14)(1.08)

Things to note about BIO Key International performance evaluation

Checking the ongoing alerts about BIO Key for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for BIO Key International help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
BIO Key has some characteristics of a very speculative penny stock
BIO Key has high likelihood to experience some financial distress in the next 2 years
The company reported the previous year's revenue of 6.93 M. Net Loss for the year was (4.3 M) with profit before overhead, payroll, taxes, and interest of 5.09 M.
BIO Key International currently holds about 4.89 M in cash with (2.91 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.58.
BIO Key has a frail financial position based on the latest SEC disclosures
Roughly 16.0% of the company shares are held by company insiders
Latest headline from news.google.com: Bio key international - AInvest
Evaluating BIO Key's performance can involve analyzing a variety of financial metrics and factors. Some of the key considerations to evaluate BIO Key's stock performance include:
  • Analyzing BIO Key's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
  • Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether BIO Key's stock is overvalued or undervalued compared to its peers.
  • Examining BIO Key's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
  • Evaluating BIO Key's management team can have a significant impact on its success or failure. Reviewing the track record and experience of BIO Key's management team can help you assess the Company's leadership.
  • Pay attention to analyst opinions and ratings of BIO Key's stock. These opinions can provide insight into BIO Key's potential for growth and whether the stock is currently undervalued or overvalued.
It's essential to remember that evaluating BIO Key's stock performance is not an exact science, and many factors can impact BIO Key's stock market price. Therefore, it's also important to diversify your portfolio and not rely solely on one company or stock for your investments.

Complementary Tools for BIO Stock analysis

When running BIO Key's price analysis, check to measure BIO Key's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BIO Key is operating at the current time. Most of BIO Key's value examination focuses on studying past and present price action to predict the probability of BIO Key's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BIO Key's price. Additionally, you may evaluate how the addition of BIO Key to your portfolios can decrease your overall portfolio volatility.
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world